Dr Jelena Dimitrijević

Specialist in Internal Medicine and subspecialist in Oncology with more than 18 years of clinical experience in the field of oncology. Her professional interests are focused on the treatment of patients with hematological malignancies, sarcomas, lung cancer, and gastrointestinal tumors, as well as supportive oncology, with a special focus on the prevention and management of adverse effects of antineoplastic therapy, patient safety, and preservation of quality of life. She is a lecturer and participant at numerous professional meetings in the fields of oncology and supportive oncology, with more than 15 years of experience in clinical and translational research. She is actively involved in academic work as a Clinical Assistant at the Department of Clinical Oncology with Radiotherapy, Faculty of Medicine, University of Belgrade. Her professional focus is on providing high-quality medical care, professional patient communication, and continuous professional and scientific development in accordance with modern medical standards and trends.

Education:

1998 – 2006
Integrated Academic Studies, Faculty of Medicine, University of Belgrade
Graduated as Doctor of Medicine in June 2006.

2011 – 2016
Specialization in Internal Medicine, Faculty of Medicine, University of Belgrade
Obtained the title of Specialist in Internal Medicine in June 2016.

2018 – 2021
Subspecialization in Oncology, Faculty of Medicine, University of Belgrade
Obtained the title of Subspecialist in Oncology in March 2021.

Professional Experience:

2007 – Present, Medical Oncologist
Intensive Oncology Care Unit, Institute for Oncology and Radiology of Serbia, Belgrade

• Comprehensive management of patients with solid tumors, sarcomas, and lymphomas
• Administration of standard and high-dose chemotherapy, immunotherapy, ADC therapies, and bispecific antibodies
• Management of oncologic emergencies
• Pre-apheresis procedures for patients undergoing ASCT preparation
• Prevention, assessment, and treatment of adverse effects related to antineoplastic therapy
• Symptom assessment and management
• Collaboration within multidisciplinary teams
• Education of medical students, residents, and nursing staff
• Supervision and improvement of clinical quality and team communication

2023 – Present, Head of Department
Day Hospital for Supportive Oncology, Institute for Oncology and Radiology of Serbia, Belgrade

• Organization and coordination of daily clinical work within the supportive oncology unit
• Comprehensive oncological assessment prior to treatment initiation
• Prevention and management of treatment-related adverse effects
• Symptom management in patients with malignant diseases
• Administration of supportive and interventional therapies according to current guidelines
• Educational and organizational leadership activities

2023 – Present, Clinical Assistant
Department of Clinical Oncology with Radiotherapy, Faculty of Medicine, University of Belgrade

• Organization and implementation of theoretical and practical teaching in oncology and radiotherapy
• Mentorship of residents in Medical Oncology